New study targets ovarian cancer treatment in black women
NCT ID NCT06412120
First seen Nov 01, 2025 · Last updated May 15, 2026 · Updated 22 times
Summary
This study looks at how well women of African ancestry with ovarian cancer tolerate a maintenance drug called niraparib after initial treatment. Niraparib blocks cancer cells from repairing their DNA, which may slow or stop tumor growth. Researchers will track side effects and explore how genetic and environmental factors affect the drug's safety and metabolism. About 70 participants will take niraparib for up to 3 years.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for OVARIAN CANCER are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
Ahmadu Bello University Teaching Hospital (ABUTH)
RECRUITINGZaria, Kaduna State, Nigeria
Contact Email: •••••@•••••
Contact
-
Broward Health
RECRUITINGFort Lauderdale, Florida, 33316, United States
Contact Email: •••••@•••••
Contact
-
University of Miami
RECRUITINGMiami, Florida, 33136, United States
Contact
Contact
Conditions
Explore the condition pages connected to this study.